Sign In

Communications of the ACM

ACM Opinion

Why Big Pharma Wants to Collect 2 Million Genomes


View as: Print Mobile App Share: Send by email Share on reddit Share on StumbleUpon Share on Hacker News Share on Tweeter Share on Facebook
David Goldstein, Columbia

Geneticist David Goldstein will help the company to incorporate genetic sequences into better drug-development programmes.

Credit: AstraZeneca

Five months after announcing its intentions to gather genome sequences from 2 million people, pharmaceutical giant AstraZeneca has selected geneticist David Goldstein to head up the task.

From Nature
View Full Article

 


 

No entries found